-
Je něco špatně v tomto záznamu ?
The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma
H. Horka, V. Staudt, M. Klein, C. Taube, S. Reuter, N. Dehzad, JF. Andersen, J. Kopecky, H. Schild, M. Kotsyfakis, M. Hoffmann, B. Gerlitzki, M. Stassen, T. Bopp, E. Schmitt,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1998 do Před 1 rokem
Freely Accessible Science Journals
od 1998-01-01 do Před 1 rokem
Open Access Digital Library
od 1998-01-01
PubMed
22327077
DOI
10.4049/jimmunol.1100529
Knihovny.cz E-zdroje
- MeSH
- bronchiální astma imunologie metabolismus prevence a kontrola MeSH
- cystatiny imunologie farmakologie MeSH
- cytokiny imunologie metabolismus MeSH
- ELISA MeSH
- interleukin-9 biosyntéza imunologie MeSH
- Ixodidae imunologie MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední BALB C MeSH
- myši knockoutované MeSH
- myši MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- průtoková cytometrie MeSH
- separace buněk MeSH
- T-lymfocyty - podskupiny imunologie metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Ticks developed a multitude of different immune evasion strategies to obtain a blood meal. Sialostatin L is an immunosuppressive cysteine protease inhibitor present in the saliva of the hard tick Ixodes scapularis. In this study, we demonstrate that sialostatin L strongly inhibits the production of IL-9 by Th9 cells. Because we could show recently that Th9-derived IL-9 is essentially involved in the induction of asthma symptoms, sialostatin L was used for the treatment of experimental asthma. Application of sialostatin L in a model of experimental asthma almost completely abrogated airway hyperresponsiveness and eosinophilia. Our data suggest that sialostatin L can prevent experimental asthma, most likely by inhibiting the IL-9 production of Th9 cells. Thus, alternative to IL-9 neutralization sialostatin L provides the basis for the development of innovative therapeutic strategies to treat asthma.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024035
- 003
- CZ-PrNML
- 005
- 20121207125510.0
- 007
- ta
- 008
- 120815e20120210xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4049/jimmunol.1100529 $2 doi
- 035 __
- $a (PubMed)22327077
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Horka, Helena $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic and Faculty of Science, University of South Bohemia, 37005 České Budějovice, Czech Republic.
- 245 14
- $a The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma / $c H. Horka, V. Staudt, M. Klein, C. Taube, S. Reuter, N. Dehzad, JF. Andersen, J. Kopecky, H. Schild, M. Kotsyfakis, M. Hoffmann, B. Gerlitzki, M. Stassen, T. Bopp, E. Schmitt,
- 520 9_
- $a Ticks developed a multitude of different immune evasion strategies to obtain a blood meal. Sialostatin L is an immunosuppressive cysteine protease inhibitor present in the saliva of the hard tick Ixodes scapularis. In this study, we demonstrate that sialostatin L strongly inhibits the production of IL-9 by Th9 cells. Because we could show recently that Th9-derived IL-9 is essentially involved in the induction of asthma symptoms, sialostatin L was used for the treatment of experimental asthma. Application of sialostatin L in a model of experimental asthma almost completely abrogated airway hyperresponsiveness and eosinophilia. Our data suggest that sialostatin L can prevent experimental asthma, most likely by inhibiting the IL-9 production of Th9 cells. Thus, alternative to IL-9 neutralization sialostatin L provides the basis for the development of innovative therapeutic strategies to treat asthma.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bronchiální astma $x imunologie $x metabolismus $x prevence a kontrola $7 D001249
- 650 _2
- $a separace buněk $7 D002469
- 650 _2
- $a cystatiny $x imunologie $x farmakologie $7 D015891
- 650 _2
- $a cytokiny $x imunologie $x metabolismus $7 D016207
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a interleukin-9 $x biosyntéza $x imunologie $7 D016906
- 650 _2
- $a Ixodidae $x imunologie $7 D026863
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Staudt, Valérie
- 700 1_
- $a Klein, Matthias
- 700 1_
- $a Taube, Christian
- 700 1_
- $a Reuter, Sebastian
- 700 1_
- $a Dehzad, Nina
- 700 1_
- $a Andersen, John F $7 gn_A_00006077
- 700 1_
- $a Kopecky, Jan
- 700 1_
- $a Schild, Hansjörg
- 700 1_
- $a Kotsyfakis, Michalis
- 700 1_
- $a Hoffmann, Markus
- 700 1_
- $a Gerlitzki, Bastian
- 700 1_
- $a Stassen, Michael
- 700 1_
- $a Bopp, Tobias
- 700 1_
- $a Schmitt, Edgar
- 773 0_
- $w MED00002741 $t Journal of immunology (Baltimore, Md. : 1950) $x 1550-6606 $g Roč. 188, č. 6 (20120210), s. 2669-76
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22327077 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20121207125544 $b ABA008
- 999 __
- $a ok $b bmc $g 946183 $s 781363
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 188 $c 6 $d 2669-76 $e 20120210 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741
- LZP __
- $a Pubmed-20120815/12/02